ALESSIO, ENZO
 Distribuzione geografica
Continente #
NA - Nord America 22.641
EU - Europa 13.418
AS - Asia 10.113
SA - Sud America 1.263
AF - Africa 251
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 26
Totale 47.741
Nazione #
US - Stati Uniti d'America 22.363
SG - Singapore 3.645
DE - Germania 2.880
CN - Cina 2.463
IT - Italia 1.843
SE - Svezia 1.763
UA - Ucraina 1.599
RU - Federazione Russa 1.084
GB - Regno Unito 1.008
BR - Brasile 982
HK - Hong Kong 946
VN - Vietnam 926
PL - Polonia 837
KR - Corea 685
FI - Finlandia 659
FR - Francia 597
TR - Turchia 567
IE - Irlanda 298
BG - Bulgaria 295
IN - India 218
BD - Bangladesh 178
CA - Canada 162
NL - Olanda 153
AR - Argentina 114
CH - Svizzera 86
ES - Italia 68
MX - Messico 68
ID - Indonesia 55
IQ - Iraq 55
JP - Giappone 52
ZA - Sudafrica 50
SA - Arabia Saudita 49
EC - Ecuador 46
BE - Belgio 40
SN - Senegal 40
EG - Egitto 36
AT - Austria 35
MA - Marocco 35
PH - Filippine 33
CL - Cile 29
CO - Colombia 28
PK - Pakistan 28
EU - Europa 26
KE - Kenya 24
RO - Romania 23
VE - Venezuela 23
CZ - Repubblica Ceca 21
GR - Grecia 21
CI - Costa d'Avorio 20
PT - Portogallo 20
TH - Thailandia 20
AU - Australia 18
JO - Giordania 18
UZ - Uzbekistan 18
RS - Serbia 17
PY - Paraguay 16
TW - Taiwan 16
AZ - Azerbaigian 14
AE - Emirati Arabi Uniti 12
LT - Lituania 12
DZ - Algeria 11
GE - Georgia 11
IL - Israele 11
IR - Iran 11
KZ - Kazakistan 11
NP - Nepal 11
JM - Giamaica 10
MY - Malesia 10
TN - Tunisia 10
UY - Uruguay 10
HU - Ungheria 8
PA - Panama 8
BO - Bolivia 7
HR - Croazia 7
NZ - Nuova Zelanda 7
OM - Oman 7
TT - Trinidad e Tobago 7
BA - Bosnia-Erzegovina 6
DO - Repubblica Dominicana 6
KW - Kuwait 6
PE - Perù 6
SK - Slovacchia (Repubblica Slovacca) 6
KG - Kirghizistan 5
LV - Lettonia 5
PS - Palestinian Territory 5
AL - Albania 4
BH - Bahrain 4
BY - Bielorussia 4
CR - Costa Rica 4
DK - Danimarca 4
EE - Estonia 4
LB - Libano 4
LK - Sri Lanka 4
NG - Nigeria 4
QA - Qatar 4
BW - Botswana 3
GA - Gabon 3
HN - Honduras 3
NO - Norvegia 3
SI - Slovenia 3
Totale 47.694
Città #
Woodbridge 2.419
Ann Arbor 2.344
Singapore 2.200
Fairfield 1.925
Houston 1.773
Ashburn 1.666
Jacksonville 1.398
Chandler 1.137
San Jose 1.106
Wilmington 1.041
Hong Kong 928
Seattle 795
Hefei 769
Seoul 681
Cambridge 649
Warsaw 547
Princeton 523
Beijing 502
Izmir 494
Boardman 465
Chicago 337
Trieste 320
Ho Chi Minh City 292
Sofia 292
Dublin 285
Munich 268
Milan 261
Zgierz 257
Columbus 253
Lauterbourg 246
Dearborn 222
Santa Clara 221
Los Angeles 219
Hanoi 212
Dallas 202
Moscow 184
Buffalo 175
Helsinki 145
The Dalles 132
San Diego 125
Council Bluffs 122
Düsseldorf 84
Frankfurt am Main 79
New York 73
Redwood City 73
Verona 72
Bern 70
Mcallen 67
São Paulo 67
London 61
Guangzhou 60
Nanjing 53
Phoenix 52
Mestre 49
Des Moines 48
Montréal 48
Orem 47
Rio de Janeiro 41
Dakar 40
Rome 40
Shanghai 40
Haiphong 39
Chennai 38
Da Nang 38
Tokyo 38
Norwalk 37
Kocaeli 34
Kunming 33
Montreal 33
Turku 32
Miano 31
Tianjin 31
Brussels 30
Redondo Beach 28
Atlanta 27
Amsterdam 26
Casablanca 25
Denver 24
San Francisco 24
Bremen 23
Toronto 23
Brooklyn 22
Zhengzhou 22
Andover 21
Can Tho 21
Jinan 21
Mexico City 21
Abidjan 20
Johannesburg 20
Ottawa 20
Wuhan 20
Baghdad 19
Dhaka 19
Hangzhou 19
Jeddah 19
Nairobi 19
Nanchang 19
Vienna 19
Manchester 18
Naples 18
Totale 30.287
Nome #
Chimica Inorganica, seconda edizione italiana condotta sulla quinta edizione inglese 657
Neutral 1,3,5-Triaza-7-phosphaadamantane-Ruthenium(II) Complexes as Precursors for the Preparation of Highly Water-Soluble Derivatives 600
Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity 395
New Insight into a Deceptively Simple Reaction: The Coordination of bpy to RuII-Carbonyl Precursors - The Central Role of thefac-[Ru(bpy)Cl(CO)3]+Intermediate and theChloride Rebound Mechanism 381
1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for thepreparation of ruthenium complexes with potential anticancer activity 367
New Cationic and Neutral Ru(II)- and Os(II)-dmso carbonyl Compounds 363
Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective 331
A noncovalently linked, dynamic fullerene porphyrin dyad. Efficient formation of long-lived charge separated states through complex dissociation. 307
Side-to-face ruthenium porphyrin arrays. Photophysical behavior of dimeric and pentameric systems. 301
Palladium complexes with simple iminopyridines as catalysts for polyketone synthesis 299
(15)N NMR spectroscopy unambiguously establishes the coordination mode of the diimine linker 2-(2'-pyridyl)pyrimidine-4-carboxylic acid (cppH) in Ru(II) complexes 297
A spectroscopic study of the reaction of NAMI, a novel ruthenium(III) anti-neoplastic complex, with bovine serum albumin 277
New salts of anionic complexes of Ru(III) as antimetastatic and antineoplastic agents. 276
Rare Example of Stereoisomeric 2 + 2 Metallacycles of Porphyrins Featuring Chiral-at-Metal Octahedral Ruthenium Corners 275
Design of photoactivatable metallodrugs: Selective and rapid light-induced ligand dissociation from half-sandwich [Ru([9]aneS3)(N–N′)(py)]2+ complexes 272
Synthesis, Molecular Structure and Chemical Behavior of Hydrogen trans-bis(Dimethylsulfoxide)Tetrachlororuthenate(III) and mer-Trichlorotris(Dimethylsulfoxide)Ruthenium(III) - the First Fully Characterized Chloride Dimethylsulfoxide Ruthenium(III) Complexes 270
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry 267
A categorization of metal anticancer compounds based on their mode of action. 257
Complessi dicarbossilati del rutenio(II) e loro impiego come antitumorali 256
null 252
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy 249
Sulfoxide ruthenium complexes: non toxic tools for the selective treatment of solid tumour metastases. 247
Antitumor action of mer-trichlorobis(dimethyl sulfoxide)aminoruthenium(III) (BBR2382) in mice bearing Lewis lung carcinoma 242
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 239
Activation of Rh6(CO)16 with 1,10-phenanthroline and substituted derivatives in the catalytic reduction of nitrobenzene to aniline with carbon monoxide and water 238
Synthesis and characterization of new halogen -tetramethylene sulfoxide-ruthenium(II) and ruthenium(III) complexes; crystal structure of cis-dichlorotetrakis(tetramethylene sulfoxide) ruthenium(II) and hydrogen trans-bis(tetramethylene sulfoxide)tetrachlororuthenate(III) 236
The Insertion of Ruthenium into Porphyrins Revisited and Improved: Proof of Concept Results with a Ruthenium(II) Monocarbonyl Compound, and the Spectacular Effect of Propionic Acid 236
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 234
Discrete Supramolecular Assemblies of Porphyrins Mediated by Coordination Compounds 234
Response of MCa mammary carcinoma to cisplatin and to Na[trans-RuCl4(DMSO)(Im)]. 233
Solution and solid state structure of a canted, side-to-face, bis-porphyrin adduct. 232
New atropisomeric bidentate nitrogen-donor compounds as potential stereocontrollers in mild CO-styrene copolymerisation catalysed by palladium(II) salts. 232
Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors 232
The rare head-to-head conformation of untethered lopsided ligands discovered in both solution and solid states of 1,5,6-trimethylbenzimidazole Re(V) and Ru(II) complexes. 229
Ruthenium(III) complexes as antineoplastic agents. 228
The synthesis of RuBr2(DMSO)3 revisited: a mixture of Li[fac-RuClnBr3-n(DMSO)3] isomers (n = 0-3) is the reaction product 228
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels 227
A novel open-box shaped pentamer of vertically linked porphyrins that selectively recognizes S-bonded Me2SO complexes. 226
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in theLewis lung carcinoma system. 225
trans-Ru(II)dimethylsulfoxides: antineoplastic action on mouse tumors 225
Activation of carbonyl clusters with 1,10-phenanthroline and related ligands: the reduction of nitrobenzene as a model reac¬tion for MX(CO)Y (M = Ru, Os, Ir) + Phen systems as catalyst precursors 225
Water-Soluble Ruthenium(II) Carbonyls with 1,3,5-Triaza-7-phosphoadamantane 224
Antineoplastic effects of mer-RuCl3(DMSO)2(NH3) against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4]. 223
Ruthenium anticancer compounds: challenges and expectations 221
Carbonyl derivatives of chloride dimethyl-sulfoxide ruthenium(II) complexes. Synthesis, structural characterization, and reactivity of Ru(CO)(X)(Dmso)(4-X)Cl-2 complexes (X=1-3) 221
Wavelength-Dependent Electron and Energy Transfer Pathways in a Side-to-Face Ruthenium Porphyrin / Perylene Bisimide Assembly 220
Ruthenium-Porphyrin Conjugates with Cytotoxic and Phototoxic Antitumor Activity 219
Tumor inhibition and effects on host survival time by rutheniumIII andrhodiumIII complexes with dimethylsulphoxide ligands. 218
Synthesis and Properties of Novel Fullerene Derivatives 218
Phototoxic Activity and DNA Interactions of Water-Soluble Porphyrins and Their Rhenium(I) Conjugates 218
Factors that influence the antiproliferative activity of half sandwich RuII-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives. 216
Coordination and release of NO by ruthenium-dimethylsulfoxide complexes - implications for anti-metastases activity. 214
Complexed bridging ligands: oxorhenium(V) compounds with mono-coordinated pyrazine or pyrimidine as possible building-blocks for the construction of polynuclear architectures. 214
Reduction of lung metastases by Na[trans-RuCl4(DMSO)Im] is not coupled with the induction of chemical xenogenization 214
Antileukemic action of RuCl2(DMSO)4 isomers and prevention of brain involvement on P388 leukemia and on P388/DDP subline 214
Antimetastatic action and toxicity on healty tissues of Na[trans-RuCl4(DMSO)Im] in the mouse. 213
Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media 212
Complessi di Rutenio con elevata attività antitumorale 212
A Functionalized Noncovalent Macrocyclic Multiporphyrin Assembly from a Dizinc(II) Bis-Porphyrin Receptor and a Free-Base Dipyridylporphyrin 212
New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity. 212
Antimetastatic action and toxicity on healthy tissues ofNa[trans-RuCl4(DMSO)Im] in the mouse. 211
Crystals containing conformers: a rare case in which a solid closely reflects a solution equilibrium mixture 209
Synthesis, structural characterization and chemical behavior of new dimeric Ru(III) complexes 209
COMPLESSI DI Ru(III) COME AGENTI ANTINEOPLASTICI 208
Chemical properties of rare platinum metal complexes having antitumor activity 208
Efficacy of 5-FU combined to Na[trans-RuCl4(DMSO)(Im)], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline and MCa mammary carcinoma 208
Is the aromatic fragment of piano-stool ruthenium compounds an essential feature for anticancer activity? The development of new Ru(II)-[9]aneS3 analogues. 207
Metal-mediated multi-porphyrin discrete assemblies and their photoinduced properties. 207
Geometrical and linkage isomers of OsCl2(dmso)4: the complete picture 207
Synthesis and characterization of a new series of palladium(II) compounds with nitrogen-donor chelating ligands: [Pd(chel)(L)2][PF6]2 207
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties 207
Photolabile Ru Model Complexes with Chelating Diimine Ligands for Light-Triggered Drug Release 207
Complessi trans di rutenio come agenti antineoplastici 205
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[{trans-RuCl4(Me2SO)}2(μ-L)] (L=ditopic, non-chelating aromatic N-ligand). A preliminary investigation 204
Ru(ii)-Peptide bioconjugates with the cppH linker (cppH = 2-(2'-pyridyl)pyrimidine-4-carboxylic acid): synthesis, structural characterization, and different stereochemical features between organic and aqueous solvents 204
Porphyrin "flying saucers": Solid state and solution structure of a novelpentameric array of axially-ligated canted porphyrins. 203
Free exchange across cells,and echistatin-sensitive membrane target for the metastasis inhibitor NAMI-A(imidazolium trans-imidazole dimethyl sulfoxide tetrachlororuthenate)ON KB Tumor cells. 203
Structure of trans-dichlorotetrakis(dimethyl sulfoxide)rhodium(III) tetrafluoroborate 203
Two-point self-coordination of a dizinc(ii) bis-pyridylporphyrin ruthenium complex leading selectively to a discrete molecular assembly: solution and solid state characterization 202
Rhodium(III) analogues of antitumour-active ruthenium(III) compounds: the crystal structure of [ImH][trans-RhCl4(Im)2] (Im= imidazole) 202
NMR structural characterization of the reaction product between d(GpG) and the octahedral antitumor complex trans-RuCl2(DMSO)4. 200
Sistemi periodici: una proposta didattica interdisciplinare tra chimica e letteratura 200
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 199
Photo-active triads self-assembled around a pivot aluminum(III)porphyrin 199
C60 in the Box. A Supramolecular C60 - Porphyrin Assembly 198
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A 196
Novel Ru(III)-dimethyl sulfoxide catalysts for the selective oxidation of thioethers to sulfoxides with molecular oxygen 195
The NAMI A - human ferritin system: a biophysical characterization 195
Half-sandwich RuIIsingle bond[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: Preparation, structural characterization and in vitro cytotoxic activity 195
Energy Transfer Pathways in Pyridylporphyrin Re(I) Adducts. 194
Na[trans-RuCl4(DMSO)(Im)]*2DMSO - antimetastatic ruthenium agent 194
Electrochemistry of Sodium trans-bis(Dimethylsulphoxide)Tetrachlororuthenate(III) and mer-Trichlorotris(Dimethylsulphoxide)Ruthenium(III) - the First and Complete Electrochemical Characterization of Chlorodimethyl Sulfoxide Ruthenium(III) Complexes 194
Synthesis and Reactivity of Ru-, Os-, Rh-, and Ir-halide-sulfoxide Complexes. 192
Synthesis and characterization of two new classes of ruthenium(III)-sulfoxide complexes with nitrogen donor ligands (L): Na[trans-RuCl4(R2SO)(L)] and mer,cis-RuCl3(R2SO)(R2SO)(L). The crystal structure of Na[trans-RuCl4(DMSO)(NH3)]•2DMSO, Na[trans-RuCl4(DMSO)(Im)]•H2O•Me2CO (Im = imidazole) and mer,cis- RuCl3(DMSO)(DMSO)(NH3) 192
The interaction of the antitumor complexes Na[trans-RuCl4(DMSO)(Im)] and Na[trans-RuCl4(DMSO)(Ind)] with apotransferrin: a spectroscopic study 192
Carbonyl derivatives of chloride-dimethyl sulfoxide-ruthenium(III) complexes. Synthesis, crystal-structure, and reactivity of [(Dmso)(2)H][Trans-RuCl4(Dmso)(CO)] and mer, cis-RuCl3(Dmso)(2)(CO) 192
Synthesis and Characterization of Two New Classes of Ruthenium(III-Sulfoxide Complexes with Nitrogen Donor Ligands (L) - {$Na\left[\mathit{trans}-RuCl_4(R_2SO)(L)\right]$} and {$\mathit{mer,cis}-RuCl_3(R_2SO)(R_2SO)(L)$} - the crystal structure of {$Na\left[\mathit{trans}-RuCl_4(DMSO)(NH_3)\right]\cdot{}2DMSO$}, {$Na\left[\mathit{trans}-RuCl_4(DMSO)(Im)\right]\cdot{}{H_2O},{Me_2CO}$} (Im=Imidazole) and {$\mathit{mer,cis}-RuCl_3(DMSO)(DMSO)(NH_3)$} 192
Mixed-ligand rhenium(V) oxo monomers with triphenylphosphine oxide and lopsided and symmetrical heterocyclic ligands. Putative intermediates in rhenium(V) oxo synthetic chemistry 191
Towards Matched Pairs of Porphyrin-ReI/99mTcIConjugates that Combine Photodynamic Activity with Fluorescence and Radio Imaging 191
Synthesis and characterization of novel Re(I)-Porphyrin dyad and triad for photoinduced electron-transfer 191
Totale 23.725
Categoria #
all - tutte 135.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.553


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021427 0 0 0 0 0 0 0 0 0 0 0 427
2021/20223.140 146 232 197 419 70 224 94 125 355 298 213 767
2022/20233.639 373 433 264 440 436 688 32 289 433 23 169 59
2023/20241.907 173 139 91 165 194 107 206 493 15 33 167 124
2024/20255.099 84 311 470 454 463 490 458 373 564 462 369 601
2025/202611.882 957 831 1.091 1.064 933 1.190 1.657 476 1.333 1.700 484 166
Totale 48.583